有研粉材(688456.SH):擬使用募集資金向有研泰國增資4.18億泰銖 用於實施泰國產業基地建設項目
格隆匯2月24日丨有研粉材(688456.SH)公佈,公司於2022年2月23日召開第二屆董事會第一次臨時會議和第二屆監事會第一次臨時會議,審議通過了《關於使用部分募集資金向全資子(孫)公司增資用於實施募投項目的議案》,同意公司使用募集資金(人民幣8187.9萬元,具體以實時匯率為準)向全資子(孫)公司GRIPM ADVANCED MATERIALS (Thailand) Co., LTD.(簡稱有研泰國)增資4.18億泰銖,用於實施“泰國產業基地建設項目”,視項目實施進度安排資金分批撥付。本次增資完成後,有研泰國為公司全資子(孫)公司。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.